Serina Therapeutics

Serina Therapeutics is a clinical-stage biotechnology company developing a pipeline of wholly owned drug candidates for the treatment of neurological disorders and pain. Serina’s POZ Platform™ delivery technology is designed to provide better drug loading control and more precise attached drug release rates, enabling certain challenging small molecule drugs to achieve their full therapeutic potential while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. Partners of Serina Therapeutics’ POZ Platform™ are at the forefront of LNP delivery technology and are committed to developing novel RNA therapeutics.